These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2314191)

  • 1. Role of angiotensin II and vasopressin in cisplatin-induced emesis.
    Cubeddu LX; Lindley CM; Wetsel W; Carl PL; Negro-Vilar A
    Life Sci; 1990; 46(10):699-705. PubMed ID: 2314191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
    Kenward H; Elliott J; Lee T; Pelligand L
    BMC Vet Res; 2017 Aug; 13(1):244. PubMed ID: 28814338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms by which cancer chemotherapeutic drugs induce emesis.
    Cubeddu LX
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):2-13. PubMed ID: 1485177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration.
    Kenward H; Pelligand L; Elliott J
    Exp Brain Res; 2014 Aug; 232(8):2685-97. PubMed ID: 24792501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine vasopressin modulates the central action of angiotensin II in the dog.
    Michelini LC; Barnes KL; Ferrario CM
    Hypertension; 1983; 5(6 Pt 3):V94-100. PubMed ID: 6654469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin, fluid, and electrolyte response to chronic angiotensin II infusion.
    Cowley AW; Switzer SJ; Skelton MM
    Am J Physiol; 1981 Mar; 240(3):R130-8. PubMed ID: 7212084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study on the control of cisplatin-induced emesis in dogs].
    Ito J; Okada M; Abo T; Okamoto Y; Yamashita T; Takahashi K
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):706-10. PubMed ID: 3827261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nonpeptide vasopressin V(1a) receptor antagonist, SR 49059, does not prevent cisplatin-induced emesis in piglets.
    Grélot L; Girod V; Dapzol J; Maffrand JP; Serradeil-Le Gal C
    Fundam Clin Pharmacol; 2001 Jun; 15(3):189-200. PubMed ID: 11468030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine vasopressin--a mediator of chemotherapy induced emesis?
    Edwards CM; Carmichael J; Baylis PH; Harris AL
    Br J Cancer; 1989 Mar; 59(3):467-70. PubMed ID: 2930716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three preclinical models for nausea and vomiting assessment.
    Goineau S; Castagné V
    J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal responses of metoclopramide-treated subjects experiencing nausea or emesis during parabolic flight.
    Kohl RL
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A266-9. PubMed ID: 2823788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo.
    Navari RM; Madajewicz S; Anderson N; Tchekmedyian NS; Whaley W; Garewal H; Beck TM; Chang AY; Greenberg B; Caldwell KC
    J Clin Oncol; 1995 Sep; 13(9):2408-16. PubMed ID: 7666101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of vasopressin in stimulation of ACTH secretion by angiotensin II in conscious dogs.
    Klingbeil CK; Keil LC; Chang D; Reid IA
    Am J Physiol; 1986 Jul; 251(1 Pt 1):E52-7. PubMed ID: 3014891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emetic effects of centrally administered angiotensin II, arginine vasopressin and neurotensin in the dog.
    Wu M; Harding RK; Hugenholtz H; Kucharczyk J
    Peptides; 1985; 6 Suppl 1():173-5. PubMed ID: 4047979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ondansetron: prevention of nausea & vomiting in cisplatin based chemotherapy.
    Cheirsilpa A; Ratanatharathorn V; Sinlarat P; Chindavijak K; Lousoontornsiri W; Chakrapee-Sirisuk S; Srimuninimit V
    J Med Assoc Thai; 1994 Apr; 77(4):201-6. PubMed ID: 7844494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
    Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ
    Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin and ANG II in the control of ACTH secretion and arterial and atrial pressures.
    Brooks VL
    Am J Physiol; 1989 Feb; 256(2 Pt 2):R339-47. PubMed ID: 2537037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic actions and interactions of arginine vasopressin, angiotensin-II, and oxytocin on adrenocorticotropin secretion by rat anterior pituitary cells in the microperifusion system.
    Watanabe T; Oki Y; Orth DN
    Endocrinology; 1989 Oct; 125(4):1921-31. PubMed ID: 2551632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.